Substrate cooperativity shapes competitive inhibitor responses in mycobacterial inosine 5'-monophosphate dehydrogenase
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
41495879
PubMed Central
PMC12781933
DOI
10.1080/14756366.2025.2598479
Knihovny.cz E-zdroje
- Klíčová slova
- IMPDH, cooperativity, inhibitors, mycobacteria,
- MeSH
- IMP-dehydrogenasa * antagonisté a inhibitory metabolismus MeSH
- inhibitory enzymů * farmakologie chemie chemická syntéza MeSH
- kinetika MeSH
- koncentrace vodíkových iontů MeSH
- molekulární struktura MeSH
- Mycobacterium tuberculosis * enzymologie MeSH
- Mycobacterium * enzymologie MeSH
- substrátová specifita MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- IMP-dehydrogenasa * MeSH
- inhibitory enzymů * MeSH
Inosine 5'-monophosphate dehydrogenase (IMPDH) is a promising antimicrobial target due to its central role in guanine nucleotide biosynthesis. Accurate and reliable kinetic measurements are essential for evaluating inhibitors. However, the enzyme's complex reaction mechanism and substrate cooperativity complicate analysis, leading to inconsistent reports on IMPDH reaction kinetics in key pathogenic mycobacteria. Here, we present an in-depth biochemical analysis of mycobacterial IMPDH, revealing pH-dependent cooperativity mediated by IMP-driven interactions between catalytic domains within the tetramer. This mechanism may result in paradoxical activation by IMP-competitive inhibitors under specific substrate conditions. We further show that such effects may influence apparent inhibition by the natural allosteric regulators GTP and ppGpp. Based on these findings, we outline practical recommendations for designing kinetic experiments that reflect physiologic conditions with the aim of more accurately evaluating IMPDH inhibitors for drug discovery.
Zobrazit více v PubMed
Shu Q, Nair V.. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery. Med Res Rev. 2008;28(2):219–232. PubMed
Singh V, Donini S, Pacitto A, Sala C, Hartkoorn RC, Dhar N, Keri G, Ascher DB, Mondésert G, Vocat A, et al. The inosine monophosphate dehydrogenase, GuaB2, is a vulnerable new bactericidal drug target for tuberculosis. ACS Infect Dis. 2017;3(1):5–17. PubMed PMC
Hedstrom L, Liechti G, Goldberg JB, Gollapalli DR.. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors. Curr Med Chem. 2011;18(13):1909–1918. PubMed PMC
Chen L, Wilson DJ, Xu Y, Aldrich CC, Felczak K, Sham YY, Pankiewicz KW.. Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and PubMed PMC
Usha V, Gurcha SS, Lovering AL, Lloyd AJ, Papaemmanouil A, Reynolds RC, Besra GS.. Identification of novel diphenyl urea inhibitors of Mt-GuaB2 active against PubMed
Cox JAG, Mugumbate G, Del Peral LV-G, Jankute M, Abrahams KA, Jervis P, Jackenkroll S, Perez A, Alemparte C, Esquivias J, et al. Novel inhibitors of PubMed PMC
Chacko S, Boshoff HIM, Singh V, Ferraris DM, Gollapalli DR, Zhang M, Lawson AP, Pepi MJ, Joachimiak A, Rizzi M, et al. Expanding benzoxazole-based inosine 5′-monophosphate dehydrogenase (IMPDH) inhibitor structure-activity as potential antituberculosis agents. J Med Chem. 2018;61(11):4739–4756. PubMed PMC
Makowska-Grzyska M, Kim Y, Gorla SK, Wei Y, Mandapati K, Zhang M, Maltseva N, Modi G, Boshoff HI, Gu M, et al. PubMed PMC
Hedstrom L. IMP dehydrogenase: structure, mechanism, and inhibition. Chem Rev. 2009;109(7):2903–2928. PubMed PMC
Hedstrom L, Gan L.. IMP dehydrogenase: structural schizophrenia and an unusual base. Curr Opin Chem Biol. 2006;10(5):520–525. PubMed
Bulvas O, Knejzlík Z, Sýs J, Filimoněnko A, Čížková M, Clarová K, Rejman D, Kouba T, Pichová I.. Deciphering the allosteric regulation of mycobacterial inosine-5′-monophosphate dehydrogenase. Nat Commun. 2024;15(1):6673. PubMed PMC
Fernández-Justel D, Marcos-Alcalde Í, Abascal F, Vidaña N, Gómez-Puertas P, Jiménez A, Revuelta JL, Buey RM.. Diversity of mechanisms to control bacterial GTP homeostasis by the mutually exclusive binding of adenine and guanine nucleotides to IMP dehydrogenase. Protein Sci. 2022;31(5):e4314. PubMed PMC
Wang X, Rosenberg MM, Kim Y, Maltseva N, Cuny GD, Joachimiak A, Kuzmič P, Hedstrom L.. Role of the mobile active site flap in IMP dehydrogenase inhibitor binding. ACS Infect Dis. 2025;11(2):442–452. PubMed PMC
Alexandre T, Rayna B, Munier-Lehmann H.. Two classes of bacterial IMPDHs according to their quaternary structures and catalytic properties. PLOS One. 2015;10(2):e0116578. PubMed PMC
Labesse G, Alexandre T, Vaupré L, Salard-Arnaud I, Him JLK, Raynal B, Bron P, Munier-Lehmann H.. MgATP regulates allostery and fiber formation in IMPDHs. Structure. 2013;21(6):975–985. PubMed
Gedeon A, Ayoub N, Brûlé S, Raynal B, Karimova G, Gelin M, Mechaly A, Haouz A, Labesse G, Munier-Lehmann H, et al. Insight into the role of the Bateman domain at the molecular and physiological levels through engineered IMP dehydrogenases. Protein Sci. 2023;32(8):e4703. PubMed PMC
Rostirolla DC, Assunção TMd, Bizarro CV, Basso LA, Santos DS.. Biochemical characterization of
Andersen KR, Leksa NC, Schwartz TU.. Optimized PubMed PMC
Studier FW. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif. 2005;41(1):207–234. PubMed
Stefano GD, Colonna FP, Bongini A, Busi C, Mattioli A, Fiume L.. Ribavirin conjugated with lactosaminated poly-l-lysine. Biochem Pharmacol. 1997;54(3):357–363. PubMed
Knejzlík Z, Doležal M, Herkommerová K, Clarova K, Klíma M, Dedola M, Zborníková E, Rejman D, Pichová I.. The mycobacterial guaB1 gene encodes a guanosine 5′-monophosphate reductase with a cystathionine-β-synthase domain. Febs J. 2022;289(18):5571–5598. PubMed PMC
Markham GD, Bock CL, Schalk-Hihi C.. Acid − base catalysis in the chemical mechanism of inosine monophosphate dehydrogenase. Biochemistry. 1999;38(14):4433–4440. PubMed
Vandal OH, Roberts JA, Odaira T, Schnappinger D, Nathan CF, Ehrt S.. Acid-susceptible mutants of PubMed PMC
Zhang Y, Scorpio A, Nikaido H, Sun Z.. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of PubMed PMC
Rao M, Streur TL, Aldwell FE, Cook GM.. Intracellular pH regulation by PubMed
Kerr KM, Hedstrom L.. The roles of conserved carboxylate residues in IMP dehydrogenase and identification of a transition state analog. Biochemistry. 1997;36(43):13365–13373. PubMed
Gilbert HJ, Lowe CR, Drabble WT.. Inosine 5′-monophosphate dehydrogenase of PubMed PMC
Riera TV, Wang W, Josephine HR, Hedstrom L.. A kinetic alignment of orthologous inosine-5′-monophosphate dehydrogenases. Biochemistry. 2008;47(33):8689–8696. PubMed PMC
Bulvas O, Knejzlík Z, Filimoněnko A, Kouba T, Pichová I.. Conformational landscape of the mycobacterial inosine 5′-monophosphate dehydrogenase octamerization interface. J Struct Biol. 2025;217(2):108198. PubMed
Prosise GL, Wu JZ, Luecke H.. Crystal structure of PubMed